Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
August 02 2022 - 5:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2022
Commission File Number: 001-39088
Aesthetic
Medical International Holdings Group Limited
1122
Nanshan Boulevard
Nanshan District, Shenzhen
Guangdong Province, China 518052
(Address of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x Form 40-F
¨
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Aesthetic Medical International Holdings Group Limited |
|
|
|
|
By: |
/s/ Guanhua Wu |
|
Name: |
Guanhua Wu |
|
Title: |
Chief Financial Officer |
Date:
August 2, 2022
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From May 2024 to Jun 2024
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Jun 2023 to Jun 2024